Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 0.24%.

  • Vanda Pharmaceuticals' Return on Capital Employed fell 1800.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.07% for FY2024, which is 500.0% down from last year.
  • According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Return on Capital Employed is 0.24%, which was down 1800.0% from 0.2% recorded in Q2 2025.
  • Vanda Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.09% for Q3 2021, and its period low was 0.24% during Q3 2025.
  • In the last 5 years, Vanda Pharmaceuticals' Return on Capital Employed had a median value of 0.01% in 2022 and averaged 0.02%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 400bps in 2021, then tumbled by -1800bps in 2025.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Return on Capital Employed stood at 0.08% in 2021, then tumbled by -86bps to 0.01% in 2022, then tumbled by -312bps to 0.03% in 2023, then tumbled by -195bps to 0.07% in 2024, then crashed by -231bps to 0.24% in 2025.
  • Its Return on Capital Employed was 0.24% in Q3 2025, compared to 0.2% in Q2 2025 and 0.13% in Q1 2025.